Section Arrow
Quote
BNR.NASDAQ
- Burning Rock Biotech Limited
Quotes are at least 15-min delayed:2026/02/12 19:43 EST
After Hours
Last
 31
+0.73 (+2.41%)
Bid
29.23
Ask
30.5
High 31 
Low 29.23 
Volume 11 
Regular Hours (Closed)
Last
 30.27
+1.39 (+4.81%)
Day High 
30.49 
Prev. Close
28.88 
1-M High
41.72 
Volume 
29.42K 
Bid
29.23
Ask
30.5
Day Low
28.425 
Open
28.96 
1-M Low
23.4 
Market Cap 
310.94M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 32.89 
20-SMA 33.35 
50-SMA 25.6 
52-W High 41.72 
52-W Low 2.18 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-11.60/--
Enterprise Value
338.69M
Balance Sheet
Book Value Per Share
7.36
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
515.82M
Operating Revenue Per Share
7.50
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ICLRICON plc80.08-53.06-39.85%10.93PE
After Hours 81.19 +1.11 +1.39%
IQVIQVIA Holdings168.85-8.33-4.70%21.7PE
After Hours 169.902 +1.052 +0.62%
DHRDanaher Corp214.94-5.04-2.29%43.08PE
After Hours 214.74 -0.2 -0.09%
TMOThermo Fisher Scientific509.82-17.35-3.29%28.69PE
After Hours 508.25 -1.57 -0.31%
NEOGNeogen Corp10.78+0.03+0.28%-- 
After Hours 10.88 +0.1 +0.93%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.